GP6 and stroke disorder: Gp6 deficiency or inhibition suppresses thrombus formation and may still not cause a significant bleeding tendency, antibodies such as Abciximab, Glenzobimab and small molecule inhibitors as anti-thrombotic agents have been used for curing stroke clinically (Akkerhuis et al., 2001; Matsumoto et al., 2006; Wichaiyo et al., 2022).